This federal contract award, identified as SPE2DE21D7010|SPE2D625F80Y9, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Nuvasive, Inc., a medical device company specializing in spinal surgery products and services. The contract, valued at $12,059.71, is for the delivery of RELINE MAS IMPLANTS, which are specialized spinal medical devices.
Nuvasive, Inc. is a subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division and operates as a for-profit organization. The company has established itself as a key supplier of advanced spinal medical technologies to the U.S. Department of Defense (DoD), Department of Veterans Affairs (VA), and Defense Health Agency (DHA). This contract is not associated with any set-aside designation, indicating Nuvasive's strong market position in providing these specialized medical products.
The award is a delivery order contract with a fixed price and economic price adjustment pricing type. It has an ultimate completion date of January 6, 2025. Nuvasive, Inc. also holds a significant $8 million Blanket Purchase Agreement (BPA) with the DHA, which serves as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle, allowing DHA facilities nationwide to efficiently access the company's portfolio of spinal medical devices and instruments.
Generated 3/7/25, 10:07 AM